The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression
Abstract
Tripartite motif (TRIM) family proteins participate in a variety of important cellular processes, including apoptosis, cell-cycle arrest, DNA repair, and senescence. In this study, we demonstrated that a novel TRIM family member, TRIM67, was commonly silenced in colorectal cancer and its downregulation was associated with poor survival. Trim67 knockout in ApcMin/+ mice increased the incidence, multiplicity, and burden of colorectal tumors. Similarly, colon-specific knockout of Trim67 significantly accelerated azoxymethane-induced colorectal cancer in mice. RNA sequencing revealed that the antitumor effect of TRIM67 was mediated by activation of the p53 signaling pathway. TRIM67 interacted directly with the C-terminus of p53, inhibiting p53 degradation by its ubiquitin ligase MDM2. TRIM67 was also a transcriptional target of p53; upon cellular stress, p53 bound to the TRIM67 promoter and induced significant upregulation of TRIM67, thereby forming a TRIM67/p53 self-amplifying loop that boosts p53-induced cell growth inhibition and apoptosis. Consequently, loss of this p53-positive regulatory program profoundly compromised p53-mediated responses to chemotherapy-induced DNA damage. Dampened p53 response was also observed in tumors of Trim67 knockout mice and Trim67 knockout embryonic fibroblasts. TRIM67 reactivation restored p53 activation and sensitized colorectal cancer cells to chemotherapy in vitro and in vivo. TRIM67 thus functions as a pivotal tumor suppressor in colorectal cancer and is a potential target for improving chemotherapy responsiveness. Significance: The TRIM67/p53 axis represents a novel therapeutic target that could be harnessed to improve chemotherapy efficacy in colorectal cancer expressing wild-type p53 but with repressed p53 signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, TRIM67 interacted directly with the C-terminus of p53, inhibiting p53 degradation by its ubiquitin ligase MDM2 [265].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [265]
In the citing paper
“Preclinical studies have shown that TRIM67 can enhance the anti-proliferation effect of adriamycin, 5-FU or oxaliplatin in p53 wild-type CRC cells [265].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [265]
Citations
Cites
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279
Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids
Matano, M., Date, S., Shimokawa, M., Takano, A., Fujii, M., Ohta, Y., Watanabe, T., Kanai, T., & Sato, T. (2015) · Nature Medicine · doi:10.1038/nm.3802 · Cited by 1,135
TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis
Hatakeyama, S. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.002 · Cited by 960
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 879
Hatakeyama, S. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3139 · Cited by 802
Mutant p53 Gain-of-Function in Cancer
Oren, M., & Rotter, V. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001107 · Cited by 753
The genetics of the p53 pathway, apoptosis and cancer therapy
Vazquez, A., Bond, E. E., Levine, A. J., & Bond, G. L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2656 · Cited by 676
Neufert, C., Becker, C., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.279 · Cited by 675
Cited by
TRIM family contribute to tumorigenesis, cancer development, and drug resistance
Huang, N., Sun, X., Li, P., liu, X., Zhang, X., Chen, Q., & Xin, H. (2022) · Experimental Hematology & Oncology · doi:10.1186/s40164-022-00322-w · Cited by 167
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Guo, Y., Li, Q., Zhao, G., Zhang, J., Yuan, H., Feng, T., Ou, D., Gu, R. C., Li, S., Li, K., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04208-3 · Cited by 98
“For example, TRIM67 directly interacts with p53 and inhibits p53 degradation via its ubiquitin ligase MDM2 to suppress colorectal cancer initiation and progression [25].”
BackgroundYang, Y., Yuan, H., Zhao, L., Guo, S., Hu, S., Tian, M., Nie, Y., Yu, J., Zhou, C., Niu, J., et al. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-01007-x · Cited by 81
Self-citationThe translational values of TRIM family in pan-cancers: From functions and mechanisms to clinics
Zhao, G., Liu, C., Wen, X., Luan, G., Xie, L., & Guo, X. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107881 · Cited by 78
Metadata
- Authors
- Wang, S., Zhang, Y., Huang, J., Wong, C. C., Zhai, J., Li, C., Wei, G., Zhao, L., Wang, G., Wei, H., Zhao, Z., & Yu, J.
- Affiliations
- Chinese University of Hong Kong (HK)
- University of Oxford (GB)
- Sun Yat-sen University (CN)
- Hebei Medical University (CN)
- ORCID
- Venue
- Cancer Research
- Published
- 2019-08-15
- Volume
- 79
- Issue
- 16
- Pages
- 4086-4098
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2953608056
- Cited by
- 104
- References
- 36
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 13 · 2023: 22 · 2022: 24 · 2021: 18 · 2020: 6 · 2019: 4
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- RGC-GRF Hong Kong (14111216, 14106415, 14163817)
- National Natural Science Foundation of China (NSFC; No.81572758)
- Science and Technology Program Grant Shenzhen (JCYJ20170413161534162)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p53, colorectal cancer, tumor suppressor, MDM2, p53 degradation, chemosensitivity, DNA damage response, ApcMin/+ mice, TRIM family proteins
- MeSH terms
- Tripartite Motif Proteins, Adult, Aged, Aged, 80 and over, Animals, Cytoskeletal Proteins, Female, Humans, Male, Mice, Inbred BALB C, Mice, Transgenic, Middle Aged, Neoplasms, Experimental, Promoter Regions, Genetic, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Case-Control Studies, Tumor Suppressor Protein p53, Mice, Knockout, Xenograft Model Antitumor Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression. https://app.cochat.ai/papers/10.1158/0008-5472.can-18-3614
- The paper
- Wang, S., Zhang, Y., Huang, J., Wong, C. C., Zhai, J., Li, C., Wei, G., Zhao, L., Wang, G., Wei, H., Zhao, Z., & Yu, J. (2019). TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression. Cancer Research. https://doi.org/10.1158/0008-5472.can-18-3614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.